Journal of Southern Medical University ›› 2022, Vol. 42 ›› Issue (5): 705-711.doi: 10.12122/j.issn.1673-4254.2022.05.11

Previous Articles     Next Articles

TSPAN8 is involved in lipid metabolism in non-alcoholic fatty liver disease in mice

ZHANG Jia, XUE Wei, ZHANG Shujun, ZHU Yali, YANG Cheng, GAO Yue, SHI Lingfeng, HUANG Wenxiang   

  1. Department of Infectious Diseases, First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
  • Online:2022-05-20 Published:2022-06-02

Abstract: Objective To investigate the changes of tetraspanin 8 (TSPAN8) expression levels and its role in lipid metabolism during the development of non-alcoholic fatty liver disease (NAFLD). Methods Thirty male C57BL/6J mice were randomly divided into normal diet group and high-fat diet (HFD) group (n=15), and after feeding for 1, 3, and 6 months, the expression levels of TSPAN8 in the liver tissues of the mice were detected with Western blotting. In a HepG2 cell model of NAFLD induced by free fatty acids (FFA), the effect of TSPAN8 overexpression on lipid accumulation was examined using Oil Red O staining and an automated biochemical analyzer, and the mRNA expressions of the key genes involved in lipid metabolism were detected using qRT-PCR. Results Western blotting showed that compared with that in mice with normal feeding, the expression of TSPAN8 was significantly decreased in the liver tissues of mice with HFD feeding for 3 and 6 months (P<0.05). In HepG2 cells, treatment with FFA significantly decreased the expression of TSPAN8 at both the mRNA and protein levels (P< 0.01). TSPAN8 overexpression in FFA-treated cells showed significantly lowered intracellular triglyceride levels (P<0.001) and obviously reduced mRNA expression of fatty acid transport protein 5 (FATP5) (P<0.01). The expression of FATP5 was significantly increased in FFA- treated cells as compared with the control cells (P<0.001). Conclusion TSPAN8 is involved in lipid metabolism in NAFLD, and overexpression of TSPAN8 may inhibit cellular lipid deposition by reducing the expression of FATP5.

Key words: non-alcoholic fatty liver disease; tetraspanin 8; lipid metabolism